| Dap Health-centro Medico Cathedral City-69175 Ramon | |
|
69175 Ramon Rd Building A Cathedral City CA 92234-3344 | |
| (760) 321-6776 | |
| (760) 321-4036 |
| Full Name | Dap Health-centro Medico Cathedral City-69175 Ramon |
|---|---|
| Speciality | Clinic/Center |
| Location | 69175 Ramon Rd, Cathedral City, California |
| Authorized Official Name and Position | Judy Stith (CHIEF ADMINISTRATIVE OFFICER) |
| Authorized Official Contact | 7603232118 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Dap Health-centro Medico Cathedral City-69175 Ramon 1695 N. Sunrise Way Palm Springs CA 92262 Ph: (760) 323-2118 | Dap Health-centro Medico Cathedral City-69175 Ramon 69175 Ramon Rd Building A Cathedral City CA 92234-3344 Ph: (760) 321-6776 |
| NPI Number | 1619036514 |
|---|---|
| Provider Enumeration Date | 12/06/2006 |
| Last Update Date | 03/07/2024 |
| Medicare PECOS PAC ID | 1759299944 |
|---|---|
| Medicare Enrollment ID | O20070103000476 |
News Archive
The interspecies crosstalk and misdirection could have important consequences for human health, said Bonnie L. Bassler, an HHMI investigator at Princeton University whose study was published in the September 29, 2005, issue of Nature.
Prana Biotechnology Limited announced today that researchers are planning recruitment for a phase II clinical trial of the experimental drug PBT2 in Huntington's patients. There are currently no treatments for the genetic, neurodegenerative disease; Australia is increasingly seen as a leader in the development of therapies for neurologic disorders. Huntington's often affects young adults and progressively impacts the body, mind and emotions. The disease causes incapacitation and death about 15-25 years after onset.
Starting a new school or a new job, having a baby or entering retirement are major life events that significantly affect a person's physical activity level, which may lead to poorer heart health.
MannKind Corporation today announced that it has entered into a previously announced stock lending agreement pursuant to which it will lend 9,000,000 shares of its common stock to Bank of America, N.A. MannKind has also entered into an underwriting agreement with Merrill Lynch, Pierce, Fenner & Smith Incorporated ("Merrill Lynch"), an affiliate of Bank of America, pursuant to which Merrill Lynch will sell the shares at an offering price of $5.55 per share.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619036514 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 080000651 (California) | Secondary |
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
News Archive
The interspecies crosstalk and misdirection could have important consequences for human health, said Bonnie L. Bassler, an HHMI investigator at Princeton University whose study was published in the September 29, 2005, issue of Nature.
Prana Biotechnology Limited announced today that researchers are planning recruitment for a phase II clinical trial of the experimental drug PBT2 in Huntington's patients. There are currently no treatments for the genetic, neurodegenerative disease; Australia is increasingly seen as a leader in the development of therapies for neurologic disorders. Huntington's often affects young adults and progressively impacts the body, mind and emotions. The disease causes incapacitation and death about 15-25 years after onset.
Starting a new school or a new job, having a baby or entering retirement are major life events that significantly affect a person's physical activity level, which may lead to poorer heart health.
MannKind Corporation today announced that it has entered into a previously announced stock lending agreement pursuant to which it will lend 9,000,000 shares of its common stock to Bank of America, N.A. MannKind has also entered into an underwriting agreement with Merrill Lynch, Pierce, Fenner & Smith Incorporated ("Merrill Lynch"), an affiliate of Bank of America, pursuant to which Merrill Lynch will sell the shares at an offering price of $5.55 per share.
› Verified 9 days ago
Borrego Community Health Foundation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 69195 Ramon Rd Ste C3, Cathedral City, CA 92234 Phone: 855-436-1234 | |
Dap Health - Centro Medico Cathedral City - 69175 Ramon Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 69175 Ramon Rd Ste D-4, Cathedral City, CA 92234 Phone: 760-321-6776 Fax: 760-321-4036 | |
Vivien Pacold, M.d., Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 68100 Ramon Rd, C-5, Cathedral City, CA 92234 Phone: 760-321-6068 Fax: 760-770-6789 | |
Dap Health - Centro Medico Cathedral City - Dental Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 69195 Ramon Rd Ste C3, Cathedral City, CA 92234 Phone: 855-436-1234 | |
Desert Aids Project Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 69175 Ramon Rd, Cathedral City, CA 92234 Phone: 760-323-2118 | |
Desert Aids Project Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 69175 Ramon Rd Bldg A, Cathedral City, CA 92234 Phone: 760-323-2118 | |
Dap Health-stonewall Community Health Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 68555 Ramon Rd Ste 201-207, Cathedral City, CA 92234 Phone: 619-873-3538 |